[18F] F-GLN by PET/CT in Breast Cancer

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 5, 2019

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Breast Cancer

Interventions

DRUG

Fluoroglutamine [18F]F-GLN

Evaluate the kinetics and biodistribution of \[18F\]F-GLN in primary and metastatic breast cancer.

Trial Locations (1)

RECRUITING

University of Pennsylvania, Philadelphia

All Listed Sponsors

lead

Abramson Cancer Center at Penn Medicine

OTHER